Heller Theo, Saito Satoru, Auerbach Jonathan, Williams Tarice, Moreen Tzivia Rachel, Jazwinski Allison, Cruz Brian, Jeurkar Neha, Sapp Ronda, Luo Guangxiang, Liang T Jake
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2579-83. doi: 10.1073/pnas.0409666102. Epub 2005 Feb 8.
The hepatitis C virus (HCV) is a major cause of liver disease worldwide. The understanding of the viral life cycle has been hampered by the lack of a satisfactory cell culture system. The development of the HCV replicon system has been a major advance, but the system does not produce virions. In this study, we constructed an infectious HCV genotype 1b cDNA between two ribozymes that are designed to generate the exact 5' and 3' ends of HCV. A second construct with a mutation in the active site of the viral RNA-dependent RNA polymerase (RdRp) was generated as a control. The HCV-ribozyme expression construct was transfected into Huh7 cells. Both HCV structural and nonstructural proteins were detected by immunofluorescence and Western blot. RNase protection assays showed positive- and negative-strand HCV RNA. Sequence analysis of the 5' and 3' ends provided further evidence of viral replication. Sucrose density gradient centrifugation of the culture medium revealed colocalization of HCV RNA and structural proteins in a fraction with the density of 1.16 g/ml, the putative density of HCV virions. Electron microscopy showed viral particles of approximately 50 nm in diameter. The level of HCV RNA in the culture medium was as high as 10 million copies per milliliter. The HCV-ribozyme construct with the inactivating mutation in the RdRp did not show evidence of viral replication, assembly, and release. This system supports the production and secretion of high-level HCV virions and extends the repertoire of tools available for the study of HCV biology.
丙型肝炎病毒(HCV)是全球肝脏疾病的主要病因。由于缺乏令人满意的细胞培养系统,对病毒生命周期的理解受到了阻碍。HCV复制子系统的开发是一项重大进展,但该系统不会产生病毒粒子。在本研究中,我们构建了一种感染性HCV 1b基因型cDNA,其位于两个核酶之间,这两个核酶旨在生成HCV精确的5'和3'末端。构建了第二个在病毒RNA依赖性RNA聚合酶(RdRp)活性位点具有突变的构建体作为对照。将HCV-核酶表达构建体转染到Huh7细胞中。通过免疫荧光和蛋白质印迹检测到HCV结构蛋白和非结构蛋白。核糖核酸酶保护试验显示了正链和负链HCV RNA。对5'和3'末端的序列分析提供了病毒复制的进一步证据。对培养基进行蔗糖密度梯度离心显示,HCV RNA和结构蛋白在密度为1.16 g/ml的级分中共定位,这是HCV病毒粒子的推定密度。电子显微镜显示直径约为50 nm的病毒颗粒。培养基中HCV RNA的水平高达每毫升1000万拷贝。在RdRp中具有失活突变的HCV-核酶构建体未显示病毒复制、组装和释放的证据。该系统支持高水平HCV病毒粒子的产生和分泌,并扩展了可用于研究HCV生物学的工具种类。